Bristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma's Cancer Prospects

  • Post author:
  • Post category:BioPharma

The companies will also collaborate on discovery efforts to identify additional compounds from Ono’s PGE2 receptor antagonist programs.
Source: BioSpace